Individual metabolic lesions leading to pancreatic β-cells destruction in patients with diabetes result in an underlying relative or absolute insulin deficiency in T1D, whereas variable peripheral resistance to the effects of insulin or insufficient insulin production is seen in T2D (3). This evidence concerns the gene INS and type 1 diabetes mellitus.